
PMC:7787218 / 5822-6391
Annnotations
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T28 | 0-11 | Phenotype | denotes | Anaphylaxis | http://purl.obolibrary.org/obo/HP_0100845 |
T29 | 182-193 | Phenotype | denotes | anaphylaxis | http://purl.obolibrary.org/obo/HP_0100845 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
89 | 327-333 | Species | denotes | people | Tax:9606 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T21 | 0-63 | Sentence | denotes | Anaphylaxis is a treatable condition with no permanent effects. |
T22 | 64-166 | Sentence | denotes | Nevertheless, news of these reactions has raised fear about the risks of a new vaccine in a community. |
T23 | 167-569 | Sentence | denotes | These cases of anaphylaxis raise more questions than they answer; however, such safety signals are almost inevitable as we embark on vaccination of millions of people, and they highlight the need for a robust and proactive “safety roadmap” to define causal mechanisms, identify populations at risk for such reactions, and implement strategies that will facilitate management and prevention (Figure 1).6 |